Understanding rare bone and smooth muscle cancers through genomic data
Genome Characterization Unit
['FUNDING_OTHER'] · BROAD INSTITUTE, INC. · NIH-10930691
This study is all about helping people with osteosarcoma and leiomyosarcoma by creating a helpful database that gathers information from both kids and adults, so we can find better treatments and improve care for these rare cancers.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BROAD INSTITUTE, INC. (nih funded) |
| Locations | 1 site (CAMBRIDGE, UNITED STATES) |
| Trial ID | NIH-10930691 on ClinicalTrials.gov |
What this research studies
This research focuses on osteosarcoma and leiomyosarcoma, two rare types of cancer that affect bone and smooth muscle. The project aims to create a comprehensive database that includes clinical, genomic, and patient-reported data by engaging both adult and pediatric patients. By collaborating with patients, the research seeks to accelerate the discovery of new treatment strategies and improve standards of care. The initiative will involve building dedicated websites for the osteosarcoma and leiomyosarcoma communities to facilitate patient participation and data collection.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with osteosarcoma or leiomyosarcoma, including both children and adults.
Not a fit: Patients with other types of cancer or those not diagnosed with osteosarcoma or leiomyosarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and better survival rates for patients with osteosarcoma and leiomyosarcoma.
How similar studies have performed: Previous research has shown success in similar approaches to genomic data collection and patient engagement, indicating potential for impactful outcomes.
Where this research is happening
CAMBRIDGE, UNITED STATES
- BROAD INSTITUTE, INC. — CAMBRIDGE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GABRIEL, STACEY — BROAD INSTITUTE, INC.
- Study coordinator: GABRIEL, STACEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.